Published in Am J Cardiol on January 01, 1976
Delayed improvement in exercise capacity after cardioversion of atrial fibrillation to sinus rhythm. Br Heart J (1988) 1.41
Creatine phosphokinase-MB (CPK-MB) and the diagnosis of myocardial infarction. West J Med (1977) 0.94
Direct current cardioversion does not cause cardiac damage: evidence from cardiac troponin T estimation. Heart (1998) 0.94
Myocardium tissue changes caused by electrical transthoracic discharges in rats. Int Arch Med (2009) 0.89
Electric countershock and cold stress effects on liver and adrenal gland. Clinics (Sao Paulo) (2010) 0.87
Serum creatine kinase B subunit activity in diagnosis of acute myocardial infarction. Br Heart J (1980) 0.82
Relationship between canine transthoracic impedance and defibrillation threshold. Evidence for current-based defibrillation. J Clin Invest (1987) 0.78
Cardiac troponin T does not increase after electrical cardioversion for atrial fibrillation or atrial flutter. Heart (1998) 0.75
Effect of electrical cardioversion on myocardial cells in patients in intensive care. BMJ (1998) 0.75
Prevention of ventricular fibrillation after aortic declamping during cardiac surgery. Tex Heart Inst J (1988) 0.75
Factors influencing infarct size following experimental coronary artery occlusions. Circulation (1971) 7.04
Estimation of infarct size in man and its relation to prognosis. Circulation (1972) 4.19
Simulation technology for health care professional skills training and assessment. JAMA (1999) 3.49
Quantitative assessment of the extent of myocardial infarction in the conscious dog by means of analysis of serial changes in serum creatine phosphokinase activity. J Clin Invest (1971) 3.11
Digoxin metabolism in the elderly. Circulation (1969) 2.56
Rubredoxin: a new electron transfer protein from Clostridium pasteurianum. Proc Natl Acad Sci U S A (1965) 2.55
Alpha adrenergic contributions to dysrhythmia during myocardial ischemia and reperfusion in cats. J Clin Invest (1980) 2.41
Abnormal myocardial acoustic properties in diabetic patients and their correlation with the severity of disease. J Am Coll Cardiol (1992) 2.39
Adverse hemodynamic effects of interrupting chest compressions for rescue breathing during cardiopulmonary resuscitation for ventricular fibrillation cardiac arrest. Circulation (2001) 2.36
Reduction of experimental myocardial infarct size by corticosteroid administration. J Clin Invest (1973) 2.28
High-dose epinephrine results in greater early mortality after resuscitation from prolonged cardiac arrest in pigs: a prospective, randomized study. Crit Care Med (1994) 2.21
Precordial S-T segment elevation mapping: an atraumatic method for assessing alterations in the extent of myocardial ischemic injury. The effects of pharmacologic and hemodynamic interventions. Am J Cardiol (1972) 2.19
Effect of glucose-insulin-potassium infusion on myocardial infarction following experimental coronary artery occlusion. Circulation (1972) 2.10
Depressed myocardial creatine phosphokinase activity following experimental myocardial infarction in rabbit. Circ Res (1970) 2.02
Protection of jeopardized ischemic myocardium by reduction of ventricular afterload. N Engl J Med (1974) 1.92
Coronary artery reperfusion. I. Early effects on local myocardial function and the extent of myocardial necrosis. J Clin Invest (1972) 1.86
End-tidal carbon dioxide monitoring during cardiopulmonary resuscitation. A prognostic indicator for survival. JAMA (1989) 1.86
Temporal dependence of beneficial effects of coronary thrombolysis characterized by positron tomography. Am J Med (1982) 1.85
Amphipathic metabolites and membrane dysfunction in ischemic myocardium. Circ Res (1984) 1.83
Rapid active external rewarming in accidental hypothermia. JAMA (1970) 1.79
Coronary artery reperfusion. II. Reduction of myocardial infarct size at 1 week after the coronary occlusion. J Clin Invest (1972) 1.78
An improved basis for enzymatic estimation of infarct size. Circulation (1975) 1.77
Case and survival definitions in out-of-hospital cardiac arrest. Effect on survival rate calculation. JAMA (1992) 1.75
The influence of location and extent of myocardial infarction on long-term ventricular dysrhythmia and mortality. Circulation (1979) 1.75
Simulated mouth-to-mouth ventilation and chest compressions (bystander cardiopulmonary resuscitation) improves outcome in a swine model of prehospital pediatric asphyxial cardiac arrest. Crit Care Med (1999) 1.74
Chest compression and ventilation rates during cardiopulmonary resuscitation: the effects of audible tone guidance. Acad Emerg Med (1995) 1.73
Multimedia computer-assisted instruction in cardiology. Arch Intern Med (1995) 1.72
Electrocardiographic diagnosis of myocardial infarction in the presence of complete left bundle branch block. Am Heart J (1988) 1.69
Effects of nifedipine on myocardial perfusion and ischemic injury in dogs. Circ Res (1978) 1.67
Deleterious effects of methylprednisolone in patients with myocardial infarction. Circulation (1976) 1.65
Increased myocardial perfusion at rest and diminished perfusion reserve in patients with angina and angiographically normal coronary arteries. J Am Coll Cardiol (1990) 1.65
Myocardial contracture and accumulation of mitochondrial calcium in ischemic rabbit heart. Am J Physiol (1977) 1.65
On-line assessment of ventricular function by automatic boundary detection and ultrasonic backscatter imaging. J Am Coll Cardiol (1992) 1.62
Serum enzyme determinations in the diagnosis and assessment of myocardial infarction. Circulation (1972) 1.60
Characteristics of Clostridium pasteurianum ferredoxin in oxidation-reduction reactions. Biochemistry (1966) 1.58
Distribution of myocardial injury and its relation to epicardial ST-segment changes after coronary artery occlusion in the dog. Cardiovasc Res (1972) 1.58
Myocardial necrosis from direct current countershock. Effect of paddle electrode size and time interval between discharges. Circulation (1974) 1.58
Coronary thrombolysis with tissue-type plasminogen activator in patients with evolving myocardial infarction. N Engl J Med (1984) 1.57
Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome. J Clin Endocrinol Metab (1997) 1.55
Guidelines for perioperative cardiovascular evaluation for noncardiac surgery: an abridged version of the report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Mayo Clin Proc (1997) 1.52
The efficacy of an ACLS training program for resuscitation from cardiac arrest in a rural community. Ann Emerg Med (1994) 1.51
Deleterious effects due to hemorrhage after myocardial reperfusion. Am J Cardiol (1974) 1.51
Factors responsible for impaired fibrinolysis in obese subjects and NIDDM patients. Diabetes (1994) 1.50
Reduction by hyaluronidase of myocardial necrosis following coronary artery occlusion. Circulation (1972) 1.50
Optimal technique for electrical cardioversion of atrial fibrillation. Circulation (1992) 1.50
Attenuation of the synthesis of plasminogen activator inhibitor type 1 by niacin. A potential link between lipid lowering and fibrinolysis. Circulation (1995) 1.49
Myocardial perfusion pressure: a predictor of 24-hour survival during prolonged cardiac arrest in dogs. Resuscitation (1988) 1.48
Prevention of reoccluding platelet-rich thrombi in canine femoral arteries with a novel peptide antagonist of platelet glycoprotein IIb/IIIa receptors. Circulation (1989) 1.48
Prevention of arterial reocclusion after thrombolysis with recombinant lipoprotein-associated coagulation inhibitor. Circulation (1991) 1.47
Mechanisms contributing to malignant dysrhythmias induced by ischemia in the cat. J Clin Invest (1978) 1.45
Augmented myocardial perfusion reserve after coronary angioplasty quantified by positron emission tomography with H2(15)O. J Am Coll Cardiol (1990) 1.44
The mechanism of blood flow during closed chest cardiac massage in humans: transesophageal echocardiographic observations. Mayo Clin Proc (1990) 1.44
Potentiation of vasculopathy by insulin: implications from an NHLBI clinical alert. Circulation (1996) 1.42
Early estimation of myocardial damage in conscious dogs and patients with evolving acute myocardial infarction. J Clin Invest (1973) 1.42
Test of a cardiology patient simulator with students in fourth-year electives. J Med Educ (1987) 1.41
Relation between infarct size and ventricular arrhythmia. Br Heart J (1975) 1.41
Specificity of elevated serum MB creatine phosphokinase activity in the diagnosis of acute myocardial infarction. Am J Cardiol (1975) 1.40
Determinants of rebound thrombin activity after cessation of heparin in patients undergoing coronary interventions. Cathet Cardiovasc Diagn (1998) 1.38
Accumulation of lysophosphoglycerides with arrhythmogenic properties in ischemic myocardium. J Clin Invest (1978) 1.34
Ediortial: Isoenzymes of creatine phosphokinase and diagnosis of myocardial infarction. Ann Intern Med (1973) 1.33
Increased congestive heart failure after myocardial infarction of modest extent in patients with diabetes mellitus. Am Heart J (1984) 1.33
Guidelines for perioperative cardiovascular evaluation for noncardiac surgery. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). J Am Coll Cardiol (1996) 1.31
Influence of cardiac and respiratory motion on tomographic reconstructions of the heart: implications for quantitative nuclear cardiology. J Comput Assist Tomogr (1982) 1.31
Cardiac complications. Results of penetrating chest wounds involving the heart. Arch Intern Med (1974) 1.31
Hormone interactions in the isolated rabbit heart. Synthesis and coronary vasomotor effects of prostaglandins, angiotensin, and bradykinin. Circ Res (1975) 1.30
Effects of 12 months of intense exercise training on ischemic ST-segment depression in patients with coronary artery disease. Circulation (1981) 1.29
Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized, placebo-controlled trial. Circulation (1984) 1.27
Effects of dobutamine in patients with acute myocardial infarction. Am J Cardiol (1977) 1.27
Platelet reactivity characterized prospectively: a determinant of outcome 90 days after percutaneous coronary intervention. Circulation (2001) 1.24
Acute hemodynamic responses to sublingual nifedipine: dependence on left ventricular function. Circulation (1982) 1.24
Quantification of regional myocardial blood flow in vivo with H215O. Circulation (1984) 1.24
Disparate electrophysiological alterations accompanying dysrhythmia due to coronary occlusion and reperfusion in the cat. Circulation (1978) 1.23
Valvular stenosis produced by active infective endocarditis. Circulation (1967) 1.22
Clot-selective coronary thrombolysis with tissue-type plasminogen activator. Science (1983) 1.22
Thrombolysis, clot selectivity, and kinetics. Circulation (1984) 1.21
Assisted ventilation does not improve outcome in a porcine model of single-rescuer bystander cardiopulmonary resuscitation. Circulation (1997) 1.21
The dicrotic arterial pulse. Circulation (1969) 1.20
Nifedipine and conventional therapy for unstable angina pectoris: a randomized, double-blind comparison. Circulation (1984) 1.18
Isolation of low density lipoprotein from atherosclerotic vascular tissue of Watanabe heritable hyperlipidemic rabbits. Arteriosclerosis (1989) 1.17
Bedside cardiovascular examination in patients with severe chronic heart failure: importance of rest or inducible jugular venous distension. J Am Coll Cardiol (1993) 1.17
A study of chest compression rates during cardiopulmonary resuscitation in humans. The importance of rate-directed chest compressions. Arch Intern Med (1992) 1.17
Serum creatine phosphokinase (CPK ) isoenzymes after intramuscular injections, surgery, and myocardial infarction. Experimental and clinical studies. Cardiovasc Res (1973) 1.16
Postresuscitation left ventricular systolic and diastolic dysfunction. Treatment with dobutamine. Circulation (1997) 1.16
The temporal pattern of recovery of myocardial perfusion and metabolism delineated by positron emission tomography after coronary thrombolysis. J Nucl Med (1987) 1.16
Prophylaxis of early ventricular fibrillation by inhibition of acylcarnitine accumulation. J Clin Invest (1989) 1.15
Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects. Diabetes (2000) 1.14
Influence of compression rate on initial success of resuscitation and 24 hour survival after prolonged manual cardiopulmonary resuscitation in dogs. Circulation (1988) 1.14
Left atrial transport function in myocardial infarction. Importance of its booster pump function. Am J Med (1975) 1.14
Delineation of myocardial oxygen utilization with carbon-11-labeled acetate. Circulation (1987) 1.13
Imaging of thrombi with tissue-type plasminogen activator rendered enzymatically inactive and conjugated to a residualizing label. Circulation (1992) 1.13
Mitochondrial dysfunction induced by fatty acid ethyl esters, myocardial metabolites of ethanol. J Clin Invest (1983) 1.13
Cyclic adenosine monophosphate and cardiac contractility. Circ Res (1973) 1.12
Influence of time and therapy on ventricular defibrillation in dogs. Crit Care Med (1980) 1.12
Increased plasminogen activator inhibitor-1 and vasculopathy. A reconcilable paradox. Circulation (1999) 1.12
Efficacy of chest compression-only BLS CPR in the presence of an occluded airway. Resuscitation (1998) 1.12
Bystander cardiopulmonary resuscitation. Is ventilation necessary? Circulation (1993) 1.09